The Implementation of Biodiversity Footprinting
Many biodiversity risks in pharmaceutical production occur beyond direct operational control, requiring a collaborative approach to sustainability.
Biodiversity is crucial for human health, economic stability, and industrial resilience, especially in the pharmaceutical sector, which relies on natural ecosystems.
- Over 60% of pharmaceuticals come from biological sources, including plants, microbes, and marine organisms (World Health Organization [WHO], 2013).
- Industry operations contribute to biodiversity loss through land degradation, overharvesting, pollution, and habitat destruction (Newman & Cragg, 2020; Molinari et al., 2016).
Biodiversity is foundational to human health, economic stability, and industrial resilience.
Author's summary: Biodiversity footprinting is crucial for pharmaceutical sustainability.